Iqvia(FRA) QTS

Market Cap€37.02B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€223.50

-0.62%

-1.40Today

Iqvia Financials at a Glance

Market Cap

€37.02B

Revenue (TTM)

€14.57K

Net Income (TTM)

€1.18K

EPS (TTM)

€6.91

P/E Ratio

32.53

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€223.50

Volume

Open

€223.50

Price

€223.50

Volume

Open

€223.50

Previous Close

€224.90

Daily Range

€223.50 - €223.50

52-Week Range

€133.10 - €226.70

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€223.50

Volume

Open

€223.50

Previous Close

€224.90

Daily Range

€223.50 - €223.50

52-Week Range

€133.10 - €226.70

Estimated Earnings Date

N/A

QTS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Iqvia

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

94,000

CEO

Ari Bousbib, MBA

Website

www.iqvia.com

QTS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

22.85%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.07%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€37.02B

Shares Outstanding

164.60M

Volume

Avg. Volume

27.182

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Iqvia Performance Analysis

Iqvia annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 13,720,601,705	16.8%
2023	2023-12-31	EUR 13,840,333,040	0.9%
2024	2024-12-31	EUR 14,241,593,459	2.9%
2025	2025-12-31	EUR 14,446,498,792	1.4%

Iqvia annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 5.45	30.0%
2023	2023-12-31	EUR 6.74	23.8%
2024	2024-12-31	EUR 6.92	2.6%
2025	2025-12-31	EUR 6.95	0.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€3.76K

+1.1%

Gross Profit

€984.77

+1.1%

Gross Margin

26.20%

+1.0%

Market Cap

€37.02B

N/A

Market Cap/Employee

€0.30

+1.2%

Employees

94,000

+1.0%

Net Income

€221.90

+0.9%

EBITDA

€742.23

+1.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€15.88K

+5.1%

Total Debt

€14.21K

+1.1%

Accounts Receivable

€2.93K

+1.0%

Inventory

€0.00

N/A

Long Term Debt

€12.20K

+1.0%

Short Term Debt

€2.01K

+1.8%

Return on Assets

4.67%

+1.0%

Return on Invested Capital

6.32%

+1.2%

Free Cash Flow

€312.23

+1.4%

Operating Cash Flow

€483.19

+1.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

INTCIntel

INTCIntel$89.51+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

SOFISoFi Technologies

SOFISoFi Technologies$17.88-0.01%

Questions About QTS

What is the current price of Iqvia?

Iqvia is trading at €223.50 per share.

What is the 52-week range for Iqvia?

Over the past 52 weeks, Iqvia has traded between €133.10 and €226.70.

How much debt does Iqvia have?

As of the most recent reporting period, Iqvia reported total debt of €14.21B.

How much cash does Iqvia have on hand?

Iqvia reported €1.67B in cash and cash equivalents in its most recent financial results.

What is Iqvia’s dividend yield?

Iqvia does not currently have a dividend yield.

Iqvia(FRA) QTS

Iqvia Financials at a Glance

QTS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Iqvia

QTS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Iqvia Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About QTS

What is the current price of Iqvia?

What is the 52-week range for Iqvia?

How much debt does Iqvia have?

How much cash does Iqvia have on hand?

What is Iqvia’s dividend yield?

Premium Investing Services